EMA Approves Biocon Biologics' New mAbs Facility in India and Renews GMP Certifications for India and Malaysia Sites

"These GMP certifications across our manufacturing sites in India and Malaysia reflect Biocon Biologics' continued compliance with the highest standards of quality and our unwavering commitment to addressing patient needs globally." - Company Spokesperson "These GMP certifications across our manufacturing sites inIndiaandMalaysiareflect Biocon Biologics' continued compliance with the highest standards of quality and our unwavering commitment to addressing patient needs globally...

"These GMP certifications across our manufacturing sites in India and Malaysia reflect Biocon Biologics' continued compliance with the highest standards of quality and our unwavering commitment to addressing patient needs globally." - Company Spokesperson

For more information: www.bioconbiologics.com

Logo - https://mma.prnewswire.com/media/2143906/Biocon_Biologics_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ema-approves-biocon-biologics-new-mabs-facility-in-india-and-renews-gmp-certifications-for-india-and-malaysia-sites-302180507.html